Nexus Europa

New oral drug shows promise in clinical trial for pancreatic cancer

Nexus Europa Newsroom
Posted Nov 20, 2026, 11:30 AM UTC · In the digest of 2026-11-20-1130
New oral drug shows promise in clinical trial for pancreatic cancer
Photo: The Guardian

A clinical trial for the new oral drug daraxonrasib has shown promising results in halting tumor growth for patients with advanced pancreatic cancer.

A new oral treatment, daraxonrasib, has demonstrated potential in treating advanced pancreatic cancer, according to recent clinical trial results. In the study involving 61 participants, the drug halted tumor growth in almost all patients, while the disease became undetectable in one out of every twelve subjects. Pancreatic cancer has historically maintained low survival rates due to limited early detection and sparse effective therapies, leading medical researchers to view the trial's outcomes as a significant step forward in oncology.

Sources: The Guardian

Sources

Share